| Just Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > Innovation Management - Emotion, Habit, and Culture can be Hard to Change! |
|
Just Other Articles - Innovation Management - Emotion, Habit, and Culture can be Hard to Change!
Creativity can be defined as problem identification and idea generation whilst innovation can be defined as idea According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product selection, development and commercialisation. There are distinct processes that enhance problem identification ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in and idea generation and, similarly, distinct processes that enhance idea selection, development and commerciali lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. sation. Whilst there is no sure fire route to commercial success, these processes improve the probability that g here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe ood ideas will be generated and selected and that investment in developing and commercialising those ideas will d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro not be wasted. However, Franklin (2003) argues that even great ideas developed and commercialised brilliantly m ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ay fail to succeed due to cultural, emotional and habitual barriers. Even obviously cheaper, simpler and more ef easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi fective ideas fail to take off. Whilst there are systems such as the S-curve that help predict and determine th nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically e magnitude of these barriers and hence the risk of successful commercialisation, the very nature of them makes and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ them very hard and pin down in any quantitative or qualitative analysis. The strength of cultural, emotional an ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi d habitual barriers can be illustrated by the examples below: a) 11 million people have died of AIDS in Africa. ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a Yet there is a taboo against condom use. b) The metric system is obviously a great system and used almost the dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod world over – except in the United States. c) The ATM – cash point machines – initially failed to take off becau cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin se people believed that they did not have the right to access money so easily. d) Scurvy was prevalent for year tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen s and the cure – lemon juice – was known, yet was not recognised as a legitimate cure for centuries. e) Sewage t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel systems are only today being adopted in rural and poorer parts of the world. These topics are covered in depth ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust in the MBA dissertation on Managing Creativity & Innovation, which can be purchased (along with a Creativity and y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products Innovation DIY Audit, Good Idea Generator Software and Power Point Presentation) from http://www.managing-creat . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de ivity.com. You can also receive a regular, free newsletter by entering your email address at this site. You ar elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip e free to reproduce this article as long as no changes are made and the author's name and site URL are retained. tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:How to Find the Perfect Wholesale Business for You Profiles of the Powerful: Advertising Exec Steve Grasse
|